Eiger BioPharmaceuticals, Inc.

Industry: Biotechnology (See others in industry)

Address:
350 Cambridge Ave Suite 350
Palo Alto, CA, 94306
Phone: 650-272-6138

Filings

Date Type Incremental Cash Raw Filing
2016-04-29 New $2,999,982 SEC link
2013-10-25 New $1,097,306 SEC link
2012-05-08 Amended $1,616,194 SEC link
2012-02-06 New $17,849,996 SEC link
2011-12-22 New $500,000 SEC link
2011-11-16 New $330,000 SEC link
2011-10-28 New $200,000 SEC link
2011-09-01 New $250,000 SEC link
2011-07-12 New $400,000 SEC link
2010-10-28 New $2,500,000 SEC link
2009-12-17 New Unknown SEC link
2009-09-10 Amended Unknown SEC link
2008-04-01 Paper Filing Unknown Not Available
2007-12-21 Paper Filing Unknown Not Available
2007-10-04 Paper Filing Unknown Not Available
2005-10-28 Paper Filing Unknown Not Available

Directors and Executives (Current and Past)

Name Role
Gregg Alton Director
Fouad Azzam Director
Charles Bramlage Director
Kenneth R. Chien Director
Graham Cooper Director
David A. Cory Director, Executive
Barbara Dalton Director
Thomas J. Dietz Director
Edgar G. Engleman Director
Anthony B. Evnin Director
Todd Foley Director
Joshua Funder Director
Jeffrey S. Glenn Director
Nina Kjellson Director
Johan Kordel Director
Rebecque Laba Executive
Eduardo Bruno Martins Executive
Michael Narachi Director
Daniel Omstead Director
Joanne Quan Executive
Andrew E. Senyei Director
James P. Shaffer Executive
Lauren Silverman Director
James H. Welch Executive
Asish Xavier Director
Krisztina Zsebo Director, Executive